Sri Sai Subramanyam Challa. 2021. “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”. Journal of Population Therapeutics and Clinical Pharmacology 28 (2): 436-48. https://doi.org/10.53555/jptcp.v28i2.7421.